NCT00006864View on ClinicalTrials.gov

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2000

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

aldesleukin

Trial Locations (2)

06790

Northwestern Connecticut Oncology-Hematology Associates, Torrington

44106-5065

Ireland Cancer Center, Cleveland

Sponsors

Collaborators (1)

Chiron Corporation
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Chiron Corporation

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER

NCT00006864 - Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter